Endocrine Abstracts

A 51-year-old lady presented as an emergency with disabling, recurrent hypercalcaemia in July and August, 2015 with a peak corrected calcium of 3.94 mmol/l (normal range 2.2–2.6). She had been diagnosed with a stage 1A endometrial cancer, treated with hysterectomy and bilateral salpingo-oophorectomy in April 2014. Significant pelvic and left groin lymphadenopathy was noted, and was found to be enlarging on surveillance CT of July 2015. She was also found to have a left ki...

Current guidance recommends replacing vitamin D in patients with mild primary hyperparathyroidism although there are reports of worsening hypercalcaemia in some patients. Vitamin D replacement has also been known to cause hypercalcaemia in patients with sarcoidosis. We present a case of a patient with co-existent sarcoidosis and primary hyperparathyroidism, who developed severe hypercalcaemia following treatment with high dose Vitamin D.A 63 year old lad...

Background: General population screening for type 1 diabetes (T1D) using islet autoantibodies (IAb) is gaining international momentum, since screening reduces diabetic ketoacidosis, hospitalisation and identifies individuals eligible for future preventative treatments. Qualitative studies have only been undertaken in at-risk individuals (1). We therefore aimed to explore parents’ experiences of their child taking part in a general population T1D screening...